Fluorescence- and spin-labeled carbonic anhydrase inhibitors

Current Pharmaceutical Design

Volumn 14, Issue 7, 2008, Pages 699-707

  Cecchi, Alessandro ^a   Supuran, Claudiu T ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Carbonic anhydrase inhibitors; Extracellular pH; Fluorescent sulfonamide; hCA IX; Hypoxic tumor; Spin labeled sulfonamide

Indexed keywords

ACETAZOLAMIDE; ANTINEOPLASTIC AGENT; BENZENESULFONAMIDE DERIVATIVE; BENZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; CARBONATE DEHYDRATASE IX; DICLOFENAMIDE; ETHOXZOLAMIDE; FLUORESCENT DYE; INDISULAM; MEMBRANE PROTEIN; METHAZOLAMIDE; SULFONAMIDE; THIOUREIDOSULFONAMIDE DERIVATIVE; TUMOR MARKER; CA9 PROTEIN, HUMAN; CARBONATE DEHYDRATASE; DIAGNOSTIC AGENT; TUMOR ANTIGEN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ACIDIFICATION; CANCER CELL CULTURE; DRUG DESIGN; DRUG LABELING; DRUG RESEARCH; DRUG TARGETING; ELECTRON SPIN RESONANCE; ENZYME ACTIVE SITE; EXTRACELLULAR MATRIX; HUMAN; HYPOXEMIA; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SPIN LABELING; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY; ANIMAL; CELL HYPOXIA; CELL MEMBRANE; FLUORESCENCE; METABOLISM; PATHOLOGY; PH; PHYSIOLOGY;

ANIMALS; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; CELL HYPOXIA; CELL-MATRIX JUNCTIONS; FLUORESCENCE; FLUORESCENT DYES; HUMANS; HYDROGEN-ION CONCENTRATION; NEOPLASM PROTEINS; SPIN LABELS; TUMOR MARKERS, BIOLOGICAL;

EID: 42149083228     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208783877839     Document Type: Review

References (29)

1. Cairns R, Papandreou I, Denko N. Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment. Mol Cancer Res 2006; 4: 61-70.
2. Pastorekova S, Parkkila S, Pastorek J, Supuran CT. Carbonic anhydrases: current state of the art, therapeutic applications and futureprospects. J Enzyme Inhib Med Chem 2004; 19: 199-229.
3. Warburg O. In: Arnold Constable, The metabolism of tumours. London 1930.
4. Svastova E, Hulýkova A, Rafajova M, Zatovicova M, Gibadulinova A, Casini A, et al. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett 2004; 577: 439-45.
5. Pastorekova S, Zavadova Z, Kosal L, Babusikova O, Zavada J. A novel quasi-viral agent, MaTu, is a two-component system. Virology 1992; 187: 620-6.
6. Chegwidden WR, Spencer IM. Inflammopharmacology 1995; 3: 231-9.
7. Supuran CT, Briganti F, Tilli S, Chegwidden WR, Scozzafava A, Carbonic anhydrase inhibitors: Sulfonamides as antitumor agents? Bioorg Med Chem 2001; 9: 703-14.
8. Supuran CT, Scozzafava A, Conway J. In: CRC Press (Taylor & Francis Group), Carbonic Anhydrases: Its inhibitors and activators. Boca Raton, FL 2004.
9. Cecchi A, Hulikova A, Pastorek J, Pastorekova S, Scozzafava A, Winum JY, et al. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors. J Med Chem 2005; 48: 4834-41.
10. 2+ selectivity. J Chem Soc T2 2002; 923-7.
11. Ilies M, Vullo D, Pastorek J, Scozzafava A, Ilies M, Caproiu MT, et al. Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylamino-benzolamide derivatives. J Med Chem 2003; 46: 2187-96.
12. Casini A, Scozzafava A, Mincione F, Menabuoni L, Ilies MA, Supuran CT. Carbonic anhydrase inhibitors: Water-soluble 4-sulfamoyl-phenylthioureas as topical intraocular pressure-lowering agents with long-lasting effects. J Med Chem 2000; 43: 4884-92.
13. Alterio V, Vitale RM, Monti SM, Pedone C, Scozzafava A, Cecchi A, et al. Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX. J Am Chem Soc 2006; 128: 8329-35.
14. Supuran CT, Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008; 7: (in press).
15. Stams T, Christianson DW. X-ray crystallographic studies of mammalian carbonic anhydrase isozymes. In: Chegwidden WR, Edwards Y, Carter N, Eds. The carbonic anhydrases - new horizons; Birkhäuser Verlag: Basel, Switzerland 2000; 159-74 and references therein.
16. Temperini C, Winum JY, Montero JL, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: The X-ray crystal structure of the adduct of N-hydroxysulfamide with isozyme II explains why this new zinc binding function is effective in the design of potent inhibitors. Bioorg Med Chem Lett 2007; 17(10): 2795-801.
17. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271-5.
18. Schiemann O, Prisner TF. Long-range distance determinations in biomacromolecules by EPR spectroscopy. Q Rev Biophys 2007; 40: 1-53
19. Wee VT, Feldmann RJ, Tanis RJ, Chignell CF. A comparative study of mammalian erythrocyte Carbonic Anhydrase employing spin-labeled analogues of inhibitory sulfonamides. Mol Pharm 1976; 12: 832-43.
20. Chignell CF, Starkweather DK, Erlich RH. Synthesis of some Spin-Labeled analogs of drug molecules. J Med Chem 1972; 15(8); 876-8.
21. Erlich RH, Starkweather DK, Chignell CF. A spin-label study of human erythrocyte carbonic anhydrases B and C. Mol Pharm 1972; 9:61-73.
22. Hower JF, Henkens RW, Chesnut DB. A spin label investigation of the active site of an enzyme, bovine carbonic anhydrase. J Am Chem Soc 1971; 93: 6665-71.
23. Taylor JS, Mushak P, Coleman JE. Electron spin resonance studies of carbonic anhydrase: Sition metal ions and spin-labeled sulfonamides. Proc Natl Acad Sci USA 1970; 67: 1410-6.
24. Mushak P, Coleman JE. Electron spin resonance studies of spin-labeled carbonic anhydrase. J Biol Chem 1972; 247: 373-80.
25. Hakansson K, Wehnert A. Structure of cobalt carbonic anhydrase complexed with bicarbonate. J Biol Mol 1992; 228(4): 1212-8.
26. Cecchi A, Ciani L, Winum JY, Montero M, Scozzafava A, Ristori S, et al. Design of spin-labeled sulfonamides as carbonic anhydrase inhibitors. J Med Chem (submitted).
27. Sotgiu A, Mader K, Placidi G, Colacicchi S, Ursini CL, Alecci M. pH-sensitive imaging by low-frequency EPR: A model study for biological applications. Phys Med Biol 1998; 43: 1921-30.
28. Beasley YM, Overell BG, Petrow V, Stephenson O. Some in vitro inhibitors of carbonic anhydrase. J Pharm Pharmacol 1958; 10: 696-705
29. Cecchi A, Winum JY, Innocenti A, Vullo D, Montero JL, Scozzafava A, et al. Carbonic anhydrase inhibitors: Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide. Bioorg Med Chem Lett 2004; 6: 5775-80.